Incorporation of Gene-Environment Interaction Terms Improved the Predictive Accuracy of Tacrolimus Stable Dose Algorithms in Chinese Adult Renal Transplant Recipients.

作者: Mou‐Ze Liu , Yong‐Fang Hu , Ming‐Jie Shao , Li‐Jun Zhu , Shan Cao

DOI: 10.1002/JCPH.1379

关键词:

摘要: The narrow therapeutic window of tacrolimus necessitates daily monitoring and predictive algorithms based on genetic nongenetic factors. In this study, we constructed for stable dose in a retrospective cohort 1045 Chinese renal transplant recipients. All patients were genotyped CYP3A4 20230T>C (rs2242480), T>C (rs4646437), CYP3A5*3 6898A>G (rs776746), ABCB1 129T>C (rs3213619); c.1236C>T (rs01128503), c.2677G>T/A (rs2032582) c.3435C>T (rs1045642) polymorphisms, the effects gene-gene gene-environment interactions accuracy algorithm evaluated. wild-type rs2242480 (TT) carriers, who took calcium channel blockers had lower doses than those without concomitant medications (P < 1 × 10-4 ). contrast, there was no significant difference mutant type patients. Similarly, CYP3A5 rs776746 carriers hypertension higher = 4.10 10-3 More importantly, dose-predictive with interaction terms showed better performance terms. Our finding suggested that should be more cautious to take when they are coadministrated blockers, (AA) may need dosage combination hypertension.

参考文章(53)
Patrick Gladding, Laura Panattoni, Mark Webster, Leslie Cho, Stephen Ellis, Clopidogrel pharmacogenomics: next steps: a clinical algorithm, gene-gene interactions, and an elusive outcomes trial. Jacc-cardiovascular Interventions. ,vol. 3, pp. 995- 1000 ,(2010) , 10.1016/J.JCIN.2010.08.012
Shirley M. Tsunoda, Francesca T. Aweeka, Drug Concentration Monitoring of Immunosuppressive Agents BioDrugs. ,vol. 14, pp. 355- 369 ,(2000) , 10.2165/00063030-200014060-00002
Oliver Boughton, Gabor Borgulya, Maurizio Cecconi, Salim Fredericks, Michelle Moreton-Clack, Iain A. M. MacPhee, A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipients British Journal of Clinical Pharmacology. ,vol. 76, pp. 425- 431 ,(2013) , 10.1111/BCP.12076
R. M. F. VAN SCHIE, A. M. V. BABAJEFF, T. SCHALEKAMP, J. A. M. WESSELS, S. LE CESSIE, A. de BOER, F. J. M. VAN DER MEER, E. VAN MEEGEN, T. I. VERHOEF, F. R. ROSENDAAL, A. H. MAITLAND-VAN DER ZEE, , An evaluation of gene–gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol Journal of Thrombosis and Haemostasis. ,vol. 10, pp. 767- 772 ,(2012) , 10.1111/J.1538-7836.2012.04694.X
Bao-xia He, Lei Shi, Jian Qiu, Liang Tao, Rui Li, Liang Yang, Shu-jin Zhao, A functional polymorphism in the CYP3A4 gene is associated with increased risk of coronary heart disease in the Chinese Han population. Basic & Clinical Pharmacology & Toxicology. ,vol. 108, pp. 208- 213 ,(2011) , 10.1111/J.1742-7843.2010.00657.X
Chuan-Jiang Li, Liang Li, Li Lin, Hai-Xia Jiang, Ze-Yan Zhong, Wei-Mo Li, Yan-Jun Zhang, Ping Zheng, Xu-Hui Tan, Lin Zhou, Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR Genetic Polymorphisms on Tacrolimus Metabolism in Chinese Renal Transplant Recipients PLoS ONE. ,vol. 9, pp. e86206- ,(2014) , 10.1371/JOURNAL.PONE.0086206
V. Haufroid, P. Wallemacq, V. VanKerckhove, L. Elens, M. De Meyer, D. C. Eddour, J. Malaise, D. Lison, M. Mourad, CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. American Journal of Transplantation. ,vol. 6, pp. 2706- 2713 ,(2006) , 10.1111/J.1600-6143.2006.01518.X
Masatomo Miura, Shigeru Satoh, Hideaki Kagaya, Mitsuru Saito, Kazuyuki Numakura, Norihiko Tsuchiya, Tomonori Habuchi, Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients. Pharmacogenomics. ,vol. 12, pp. 977- 984 ,(2011) , 10.2217/PGS.11.33
Pierre Wallemacq, Victor W Armstrong, Merce Brunet, Vincent Haufroid, David W Holt, Atholl Johnston, Dirk Kuypers, Yannick Le Meur, Pierre Marquet, Michael Oellerich, Eric Thervet, Burkhand Toenshoff, Nas Undre, Lutz T Weber, Ian S Westley, Michel Mourad, Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Therapeutic Drug Monitoring. ,vol. 31, pp. 139- 152 ,(2009) , 10.1097/FTD.0B013E318198D092
J. Kothari, M. Nash, J. Zaltzman, G. V. Ramesh Prasad, Diltiazem use in tacrolimus-treated renal transplant recipients. Journal of Clinical Pharmacy and Therapeutics. ,vol. 29, pp. 425- 430 ,(2004) , 10.1111/J.1365-2710.2004.00578.X